Resources
Your selections:
Clear all
Clear all
Show Filters
Process for collection of financial disclosure by clinical investigators conducting DAIDS-sponsored IND trials.
Document Date:
Guidance and requirements for daids-supported research involving recombinant DNA.
Document Date:
Required documentation of risk/benefit category and approval of clinical studies for inclusion of children by institutional review boards/ethics committees based on 45 CFR 46, Subpart D.
Document Date: